VGR Australia VGR Australia

Glyxambi
Glyxambi

4.9
Practitioners use this to address renal glucose reabsorption and improve overall glucose stability.
Ingredients
Linagliptin, Empagliflozin
Category
Diabetes Management
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Linagliptin, Empagliflozin
Reference Brand
Linagliptin/Empagliflozin
Product Origin
Generic Alternative
Reference Manufacturer
Boehringer Ingelheim
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Diabetes Management
Product Category
DPP-4 Inhibitor/SGLT2 Inhibitor Combination
Pharmacological Class
Antidiabetic Combination
Clinical Indications
Type 2 diabetes mellitus
Manufacturer Description
Formulated for type 2 diabetes mellitus to manage blood glucose levels and support metabolic stability.
Mechanism of Action
Linagliptin increases incretin levels to stimulate insulin release. Empagliflozin inhibits renal glucose reabsorption to promote its excretion in urine. This dual action targets both pancreatic and renal pathways of glucose control.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
Severe renal impairment, Dialysis, Hypersensitivity to any component
Severe Adverse Events
Pancreatitis, Diabetic ketoacidosis, Fournier's gangrene — requires immediate medical attention
Common Side Effects
Increased urination, Nasopharyngitis, Thirst
Uncommon Side Effects
Urinary tract infection, Diarrhea, Abdominal pain
Drug Interactions
Alcohol, Insulin, Rifampin, Digoxin, Diuretics
Pregnancy Safety Warnings
FDA Category C: Use not recommended in second/third trimesters. Breastfeeding: Not recommended.
Age Restrictions
Safety and efficacy in pediatric patients have not been established.
Storage Guidelines
Store at room temperature in a dry place.
Related Products
Jardiance, Trajenta, Janumet
Information related to Glyxambi is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
Where to access Antiviral Medications UK - Buy Aciclovir UK